Lisa V. Hampson

发表论文 67 篇 · 总被引 1975 次 · h-index 19

代表论文

• Sarcome-13/OS2016 trial protocol: a multicentre, randomised, open-label, phase II trial of mifamurtide combined with postoperative chemotherapy for patients with newly diagnosed high-risk osteosarcoma (2019 · BMJ Open · 被引 35)
• Defining consensus opinion to develop randomised controlled trials in rare diseases using Bayesian design: An example of a proposed trial of adalimumab versus pamidronate for children with CNO/CRMO (2019 · PLoS ONE · 被引 29)
• A New Comprehensive Approach to Assess the Probability of Success of Development Programs Before Pivotal Trials (2021 · Clinical pharmacology and therapy · 被引 22)
• Improving the assessment of the probability of success in late stage drug development (2021 · Pharmaceutical statistics · 被引 22)
• Estimands and the Patient Journey: Addressing the Right Question in Oncology Clinical Trials. (2019 · JCO Precision Oncology · 被引 19)
• Mycophenolate Mofetil Versus Cyclophosphamide for Remission Induction in Childhood Polyarteritis Nodosa: An Open‐Label, Randomized, Bayesian Noninferiority Trial (2021 · Arthritis & Rheumatology · 被引 17)